When the lung gets stiff

Journal session
Chairs: A. Dinh-Xuan (Paris, France), N. Ubags (Epalinges, Switzerland)
Aims: To describe the pathobiology, epidemiology, causes, diagnosis and treatment of idiopathic pulmonary fibrosis (IPF), the most common type of interstitial lung disease; to evaluate pulmonary fibrosis resulting from other diagnosable conditions, such as scleroderma, sarcoidosis and rheumatoid arthritis; to describe the epidemiology, biology, clinical presentation and treatment of this group of conditions; and to describe controversies in the diagnosis and treatment of rapidly progressive-interstitial lung diseases.

Idiopathic pulmonary fibrosis (IPF): epidemiology, biology, diagnosis and treatment F. Martinez (New York, United States of America)
Interstitial lung diseases (ILDs) secondary to other conditions: common biology, epidemiology, diagnosis and treatment M. Wijsenbeek (Rotterdam, Netherlands)
Pro-con debate: Does it make sense to view rapidly progressive ILD as a distinct clinical entity? - CON V. Cottin (Lyon, France)
Pro-con debate: Does it make sense to view rapidly progressive ILD as a distinct clinical entity? - PRO E. Renzoni (London, United Kingdom)